engineered immune cells

BIOLOGICAL2 trials

Sponsors

Shenzhen Geno-Immune Medical Institute

Conditions

Cancer

Phase 1

Immunotherapy Based on Tumor Associated Antigen-specific Immune Effector Cells

TerminatedNCT03535246

Shenzhen Geno-Immune Medical InstituteCancer

Start: 2025-07-01End: 2026-07-31Updated: 2026-08-24

Immunotherapy Treating GI Cancer

Not yet recruitingNCT03614650

Shenzhen Geno-Immune Medical InstituteCancer

Start: 2027-06-01End: 2028-12-31Target: 100Updated: 2026-08-26